RxDoctor Payments Data

Ann Samuel, APRN

Adult Health · Celebration, FLNPI 1215254875

Payments from drug & device makers

$416in general payments, 2019–2025

Across 16 payments — averaging $25.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$100
  • Insulet Corporation$48
  • Dexcom, Inc.$44
  • Lilly USA, LLC$35
  • Mallinckrodt Hospital Products Inc.$33
  • AbbVie$31
  • plus $124 from 6 others

What the payments were for

  • Food & beverage$416100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$416 in reported general payments places this provider in the 45th percentile of 2,237 adult health providers in Florida.

See all adult health providers in Florida

Medicare billing

Part B allowed, 2024
$57,407
Medicare patients
252
Services billed
712

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide267$428,489
JardianceEmpagliflozin193$247,368
MounjaroTirzepatide157$229,070
TrulicityDulaglutide82$120,779
FarxigaDapagliflozin Propanediol74$86,830
JanuviaSitagliptin Phosphate51$53,829
Nutropin Aq NuspinSomatropin15$37,188
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog11$28,208
Tresiba Flextouch U-100Insulin Degludec34$26,593
Lantus SolostarInsulin Glargine,hum.Rec.Anlog144$25,568
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog25$23,998
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog27$16,815
TradjentaLinagliptin14$15,406
Janumet XrSitagliptin Phos/Metformin Hcl12$14,760
Humalog Kwikpen U-100Insulin Lispro44$14,121

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Novolog$100$435,033286 claims
Lilly USA, LLCMounjaro, Trulicity, Insulin Lispro$35$351,714257 claims
Boehringer IngelheimJardiance, Tradjenta$16$262,775207 claims
AbbVieSynthroid$31$6,62268 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 2,237 adult health providers in Florida.

Other adult health in Celebration

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →